Goksen İnanc İmamoglu

5PUBLICATIONS

45CO-AUTHORS

Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 06, 2026

Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation.

|Dec 30, 2025

Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG).

Ülkü Yalçıntaş Arslan, Ferit Aslan, Murat Ayhan

|Dec 16, 2025

BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.

Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli

|Aug 03, 2021

Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.

Cengiz Karacin, Tulay Eren, Esra Zeynelgil

|Jun 03, 2020

Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.

Tulay Eren, Cengiz Karacin, Gokhan Ucar

Pageof 1

Frequent Collaborators

Nuriye Ozdemir

Omur Berna Oksuzoglu

Tulay Eren

Cengiz Karacin

Gokhan Ucar

Yakup Ergun

Ozan Yazici

Esra Zeynelgil

Mustafa Altınbaş

Osman Sutcuoglu

Frequent Collaborators

Nuriye Ozdemir

Omur Berna Oksuzoglu

Tulay Eren

Cengiz Karacin